- Home
- TIL
TIL
Instil Bio Inc.
as 05-02-2025 4:00pm EST
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 171.7M | IPO Year: | 2021 |
| Target Price: | $114.00 | AVG Volume (30 days): | 177.9K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.62 - $92.00 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Instil Bio Inc. News
TIL Breaking Stock News: Dive into TIL Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
TipRanks
2 months ago
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks
Simply Wall St.
2 months ago
Private equity firms who hold 38% of Instil Bio, Inc. (NASDAQ:TIL) gained 34%, institutions profited as well
GlobeNewswire
4 months ago
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
Zacks
6 months ago
Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
GlobeNewswire
6 months ago
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GuruFocus.com
6 months ago
Analysis of Curative Ventures V LLC's Strategic Reduction in Instil Bio Inc
GuruFocus.com
7 months ago
BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc
Compare TIL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TIL Instil Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.